Cargando…
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
BACKGROUND: Silicosis is one of the most common occupational pulmonary fibrosis caused by respirable silica-based particle exposure, with no ideal drugs at present. Metformin, a commonly used biguanide antidiabetic agent, could activate AMP-activated protein kinase (AMPK) to exert its pharmacologica...
Autores principales: | Cheng, Demin, Xu, Qi, Wang, Yue, Li, Guanru, Sun, Wenqing, Ma, Dongyu, Zhou, Siyun, Liu, Yi, Han, Lei, Ni, Chunhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365894/ https://www.ncbi.nlm.nih.gov/pubmed/34399790 http://dx.doi.org/10.1186/s12967-021-03036-5 |
Ejemplares similares
-
ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1
por: Sun, Wenqing, et al.
Publicado: (2022) -
UHRF1-mediated ferroptosis promotes pulmonary fibrosis via epigenetic repression of GPX4 and FSP1 genes
por: Liu, Yi, et al.
Publicado: (2022) -
CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner
por: Xu, Qi, et al.
Publicado: (2021) -
Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway
por: Li, Shu-xian, et al.
Publicado: (2021) -
Targeted delivery of ZNF416 siRNA-loaded liposomes attenuates experimental pulmonary fibrosis
por: Cheng, Demin, et al.
Publicado: (2022)